Tech Company Financing Transactions
USpharma Funding Round
1315 Capital participated in a funding round for USpharma. The round was announced on 6/30/2025.
Transaction Overview
Company Name
Announced On
6/30/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The comany intends to use the funds to accelerate the development and commercialization of its pipeline and scale its operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
13900 NW 57th Court
Miami Lakes, FL 33014
USA
Miami Lakes, FL 33014
USA
Phone
Website
Email Address
Overview
USpharma is a commercial-stage pharmaceutical company focused on developing and commercializing brand and pharmaceutically-equivalent products for both the consumer health and prescription markets. With industry-leading product development and manufacturing expertise, we are dedicated to providing quality healthcare products to consumers and patients in our state-of-the-art facility.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Manesh Dixit
Browse more venture capital transactions:
Prev: 6/30/2025: Epigenica venture capital transaction
Next: 6/30/2025: Stalicla venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs